Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
370 |
|
| Actual shortage: | 9 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 354 (96%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
52 (14%) |
|
Overdue reports |
2 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2022-03-01 | 2022-10-02 | 155808 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-08-16 | 2024-10-17 | 235457 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Resolved | 2021-01-15 | 2021-02-10 | 131721 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Resolved | 2021-12-17 | 2023-06-01 | 151507 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Resolved | 2021-12-17 | 2022-09-01 | 151510 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Resolved | 2022-09-01 | 2025-04-22 | 168505 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Resolved | 2023-06-01 | 2025-04-22 | 193516 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Resolved | 2020-09-17 | 2021-01-26 | 124369 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Resolved | 2023-03-10 | 2025-04-08 | 186632 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Resolved | 2020-11-20 | 2021-01-12 | 128660 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Resolved | 2021-07-29 | 2021-08-17 | 143253 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-06-08 | 158795 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Resolved | 2022-06-08 | 2022-06-15 | 162153 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Resolved | 2022-06-15 | 2022-12-04 | 162656 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Actual shortage | 2025-09-29 | 2025-12-15 | 268093 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION | Resolved | 2020-03-10 | 2021-04-21 | 108359 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2020-04-20 | 2020-05-27 | 112614 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2017-06-30 | 2017-10-28 | 14445 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2017-06-30 | 2017-08-28 | 14448 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2019-08-06 | 2020-01-16 | 91027 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2